Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cholesterol
Prototype for low cost monitor introduced, concept presented at U.S. FDA hearing
February 20th, 2005
Lifestream Technologies, Inc. (KFL), a leading supplier of cholesterol monitors, unveiled a concept product at the recent U.S. Food and Drug Administration (FDA) hearing on an over-the-counter petition for a cholesterol-lowering drug. Lifestream has filed a patent application for its new product that reduces the cost for devices used for both pharmacy and home testing of cholesterol levels. The technology under development looks like a computer mouse and embodies Lifestream's optic module and strip holder but uses a PC for the balance of the functionality. The company developed and currently markets a line of cholesterol monitors to consumers and...
Source: Medical Letter on the CDC & FDA (2005-02-20)
|
